Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses
Open Access
Abstract
Recently, attention has been paid to some medications and gastric cancer (GC) risk. This review aimed to evaluate associations between commonly used drugs and GC risk and to grade evidence from published systematic reviews and meta-analyses. This umbrella review was registered in PROSPERO (CRD42022320276). The systematic reviews and meta-analyses of observational studies were retrieved by searching Embase, PubMed, and Web of Science. The evidence strength of commonly used drugs and GC risk was categorized into four grades: weak, suggestive, highly suggestive, and strong. Of 19 associations between commonly used drugs and GC risk and its subtypes, none was supported by convincing or highly suggestive evidence. The risk of GC related to non-steroidal anti-inflammatory drugs (NSAIDs), non-aspirin NSAIDs, and acid-suppressive drugs, as well as the risk of non-cardia GC related to NSAIDs and aspirin, was supported by suggestive evidence. The results showed that a reduced GC risk was associated with two drug types (NSAIDs and non-aspirin NSAIDs), and an increased GC risk was associated with acid-suppressing drugs at the suggestive evidence level. Moreover, NSAIDs and aspirin reduced non-cardia GC risk as supported by suggestive evidence. However, the evidence supporting statins or metformin in reducing GC risk was weak, and thus future studies are required to clarify these associations.Keywords
Funding Information
- National Natural Science Foundation of China (81972322)
This publication has 146 references indexed in Scilit:
- Risk of Cancer in Diabetes: The Effect of MetforminISRN Endocrinology, 2013
- Aspirin and cancer risk: a quantitative review to 2011Annals of Oncology, 2012
- Exposure to statins and risk of common cancers: a series of nested case-control studiesBMC Cancer, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2011
- Proton pump inhibitors and risk of gastric cancer: a population-based cohort studyBritish Journal of Cancer, 2009
- Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysisBritish Journal of Cancer, 2009
- Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpressionCancer Causes & Control, 2008
- Uncertainty in heterogeneity estimates in meta-analysesBMJ, 2007
- Inflammation and cancerNature, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986